Teva Urges Court To Block Colo. EpiPen Access Program

By Theresa Schliep · October 4, 2023, 6:31 PM EDT

Generic drug giant Teva Pharmaceuticals urged a Colorado federal court on Tuesday to block a state EpiPen affordability program, calling it an unconstitutional taking of the company's product....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Teva Pharmaceuticals USA, Inc. v. Weiser et al

Case Number

Court

Colorado

Nature of Suit

Constitutionality of State Statutes

Date Filed

October 03, 2023

Recent Articles By Theresa

December 13, 2024
What's Left In $400M Skinny Label Row? A Lot, Court Says
November 27, 2024
Deloitte Posed As Consultant To Steal Vax Software, Suit Says
November 25, 2024
Hormone Therapy Co. Jilted Actress Over Image Use, Suit Says
November 25, 2024
Ex-Epstein Becker Healthcare Ace Joins Polsinelli Team
November 19, 2024
Nonpracticing Doc Can't Testify In Med Mal Case, Court Says
November 15, 2024
Despite Vaccine Spotlight, RFK Jr. A Health Policy 'Unknown'
November 14, 2024
Trump Picks RFK Jr. To Lead Health & Human Services
November 12, 2024
Why The CDC May Look Very Different In Trump's 2nd Term
November 05, 2024
Abortion Ballot Tracker: 7 States Add Protections As Fla. Effort Fails
October 29, 2024
Fla. Health Agency's All-Out Battle Against Abortion Measure